Summary.
The predictive efficacy of drugs in humans is frequently estimated from both a high affinity for their receptor as measured in vitro and a long plasmatic half-life. This is grossly misleading since one key parameter is missing: drug concentration at the receptor site in vivo. As a case study we compared the efficacies of three H1 antihistamines in inhibiting histamine-induced wheal and flare in humans at two different time points with the above mentioned parameters. It is concluded that estimating in vivo receptor occupancy, which takes into account both the affinity of the drug for the receptor and its free plasma concentration, is a far better predictor for human pharmacodynamics and hence antihistamine potency, than considering in vitro affinity and plasmatic half-life only.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 2 May 2005; returned for revision 7 June 2005; accepted by M. J. Parnham 13 June 2005
Rights and permissions
About this article
Cite this article
Gillard, M., Benedetti, M.S., Chatelain, P. et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm. res. 54, 367–369 (2005). https://doi.org/10.1007/s00011-005-1368-3
Issue Date:
DOI: https://doi.org/10.1007/s00011-005-1368-3